{"id":43336,"date":"2020-07-22T17:38:27","date_gmt":"2020-07-22T15:38:27","guid":{"rendered":"https:\/\/newserver.fyb.de\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/"},"modified":"2020-07-22T17:38:27","modified_gmt":"2020-07-22T15:38:27","slug":"baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/","title":{"rendered":"Baker McKenzie advises CureVac on strategic partnership with&nbsp;GSK"},"content":{"rendered":"<p>Munich \u2014 <strong>Baker McKen\u00adzie<\/strong> advi\u00adsed <strong>Cure\u00adVac<\/strong> AG on a stra\u00adte\u00adgic colla\u00adbo\u00adra\u00adtion agree\u00adment with <strong>Glax\u00adoS\u00admit\u00adh\u00adKline (GSK)<\/strong> to rese\u00adarch, deve\u00adlop, gene\u00adrate and commer\u00adcia\u00adlize up to five mRNA-based vacci\u00adnes and mono\u00adclonal anti\u00adbo\u00addies (mAbs) to combat infec\u00adtious dise\u00adase patho\u00adgens. The colla\u00adbo\u00adra\u00adtion comple\u00adments GSK\u2019s exis\u00adting mRNA exper\u00adtise with Cure\u00adVa\u00adc\u2019s inte\u00adgra\u00adted mRNA platform.<\/p>\n<p>Further deve\u00adlo\u00adp\u00adment of mRNA-based vacci\u00adnes and thera\u00adpies could play a criti\u00adcal role in miti\u00adga\u00adting future pande\u00admics. The two compa\u00adnies are combi\u00adning their mRNA exper\u00adtise to combat a wide range of infec\u00adtious dise\u00adase patho\u00adgens. These projects were speci\u00adfi\u00adcally selec\u00adted to take full advan\u00adtage of this plat\u00adform tech\u00adno\u00adlogy, while also addres\u00adsing unmet medi\u00adcal needs and asso\u00adcia\u00adted econo\u00admic burdens.<\/p>\n<p>Cure\u00adVac is entit\u00adled to payments for deve\u00adlo\u00adp\u00adment and regu\u00adla\u00adtory mile\u00adsto\u00adnes of up to EUR 320 million and for commer\u00adcial mile\u00adsto\u00adnes of up to EUR 380 million. \u2014 In addi\u00adtion, Cure\u00adVac recei\u00adves tiered royal\u00adties on product sales. In addi\u00adtion, GSK will make a one-time payment of EUR 120 million and a refundable payment of EUR 30 million. The latter will be due as soon as Cure\u00adVa\u00adc\u2019s indus\u00adtrial produc\u00adtion faci\u00adlity curr\u00adently under cons\u00adtruc\u00adtion in Germany has recei\u00adved its GMP (Good Manu\u00adfac\u00adtu\u00adring Prac\u00adtice) certi\u00adfi\u00adca\u00adtion from the rele\u00advant autho\u00adri\u00adties. Under the terms of the agree\u00adment, GSK will also make an equity invest\u00adment of EUR 150 million in Cure\u00adVac, repre\u00adsen\u00adting just under 10% of Cure\u00adVa\u00adc\u2019s share capital.<\/p>\n<p>\u201cWe are very plea\u00adsed to support Cure\u00adVac in this important colla\u00adbo\u00adra\u00adtion agree\u00adment with GSK, which brings toge\u00adther two world-class compa\u00adnies to further deve\u00adlop their mRNA-based vacci\u00adnes and thera\u00adpies to combat a wide range of infec\u00adtious dise\u00adase agents,\u201d commen\u00adted <strong>Dr. Constanze Ulmer-Eilfort (pictu\u00adred)<\/strong>, lead <strong>part\u00adner at Baker McKen\u00adzie<\/strong> on the transaction.<\/p>\n<p>Cure\u00adVac is a long-stan\u00adding client of Baker McKen\u00adzie. Under the leader\u00adship of Dr. Constanze Ulmer-Eilfort, Baker McKen\u00adzie advi\u00adsed Cure\u00adVac on, among other things, the colla\u00adbo\u00adra\u00adtion agree\u00adments with the Bill &amp; Melinda Gates Foun\u00adda\u00adtion and CEPI, and most recently on the stra\u00adte\u00adgic part\u00adner\u00adship with Genmab A\/S for the deve\u00adlo\u00adp\u00adment of mRNA-based anti\u00adbody thera\u00adpies (Decem\u00adber&nbsp;2019).<\/p>\n<p><strong>Legal advi\u00adsor Cure\u00adVac AG: Baker McKenzie<\/strong><br>\nLead: IP: Dr. Constanze Ulmer-Eilfort, LL.M. (Part\u00adner, Munich)<br>\nIP: Julia Schie\u00adber (Senior Asso\u00adciate, Zurich), Andreas Jauch (Senior Asso\u00adciate, Frankfurt),<br>\nAnti\u00adtrust: Dr. Chris\u00adtian Burholt (Part\u00adner, Berlin)<br>\nPharma: Dr. Thilo R\u00e4pple (Part\u00adner, Frankfurt)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Munich \u2014 Baker McKen\u00adzie advi\u00adsed Cure\u00adVac AG on a stra\u00adte\u00adgic colla\u00adbo\u00adra\u00adtion agree\u00adment with Glax\u00adoS\u00admit\u00adh\u00adKline (GSK) to rese\u00adarch, deve\u00adlop, gene\u00adrate and commer\u00adcia\u00adlize up to five mRNA-based vacci\u00adnes and mono\u00adclonal anti\u00adbo\u00addies (mAbs) to combat infec\u00adtious dise\u00adase patho\u00adgens. The colla\u00adbo\u00adra\u00adtion comple\u00adments GSK\u2019s exis\u00adting mRNA exper\u00adtise with Cure\u00adVa\u00adc\u2019s inte\u00adgra\u00adted mRNA plat\u00adform. Further deve\u00adlo\u00adp\u00adment of mRNA-based vacci\u00adnes and thera\u00adpies&nbsp;could&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":35094,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1368,1372],"tags":[],"class_list":["post-43336","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-lawyers-tax-consultants-auditors","category-consultant","news-category-deals-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Baker McKenzie advises CureVac on strategic partnership with GSK - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Baker McKenzie advises CureVac on strategic partnership with GSK - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Munich \u2014 Baker McKen\u00adzie advi\u00adsed Cure\u00adVac AG on a stra\u00adte\u00adgic colla\u00adbo\u00adra\u00adtion agree\u00adment with Glax\u00adoS\u00admit\u00adh\u00adKline (GSK) to rese\u00adarch, deve\u00adlop, gene\u00adrate and commer\u00adcia\u00adlize up to five mRNA-based vacci\u00adnes and mono\u00adclonal anti\u00adbo\u00addies (mAbs) to combat infec\u00adtious dise\u00adase patho\u00adgens. The colla\u00adbo\u00adra\u00adtion comple\u00adments GSK\u2019s exis\u00adting mRNA exper\u00adtise with Cure\u00adVa\u00adc\u2019s inte\u00adgra\u00adted mRNA platform. Further deve\u00adlo\u00adp\u00adment of mRNA-based vacci\u00adnes and thera\u00adpies could [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-22T15:38:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"347\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Baker McKenzie advises CureVac on strategic partnership with&nbsp;GSK\",\"datePublished\":\"2020-07-22T15:38:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/\"},\"wordCount\":365,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Lawyers, tax consultants, auditors\",\"Consultant\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/\",\"url\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/\",\"name\":\"Baker McKenzie advises CureVac on strategic partnership with GSK - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg\",\"datePublished\":\"2020-07-22T15:38:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg\",\"width\":620,\"height\":347},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Baker McKenzie advises CureVac on strategic partnership with&nbsp;GSK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Baker McKenzie advises CureVac on strategic partnership with GSK - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/","og_locale":"en_US","og_type":"article","og_title":"Baker McKenzie advises CureVac on strategic partnership with GSK - FYB Financial Yearbook","og_description":"Munich \u2014 Baker McKen\u00adzie advi\u00adsed Cure\u00adVac AG on a stra\u00adte\u00adgic colla\u00adbo\u00adra\u00adtion agree\u00adment with Glax\u00adoS\u00admit\u00adh\u00adKline (GSK) to rese\u00adarch, deve\u00adlop, gene\u00adrate and commer\u00adcia\u00adlize up to five mRNA-based vacci\u00adnes and mono\u00adclonal anti\u00adbo\u00addies (mAbs) to combat infec\u00adtious dise\u00adase patho\u00adgens. The colla\u00adbo\u00adra\u00adtion comple\u00adments GSK\u2019s exis\u00adting mRNA exper\u00adtise with Cure\u00adVa\u00adc\u2019s inte\u00adgra\u00adted mRNA platform. Further deve\u00adlo\u00adp\u00adment of mRNA-based vacci\u00adnes and thera\u00adpies could [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2020-07-22T15:38:27+00:00","og_image":[{"width":620,"height":347,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Baker McKenzie advises CureVac on strategic partnership with&nbsp;GSK","datePublished":"2020-07-22T15:38:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/"},"wordCount":365,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg","articleSection":["General","Featured","News","Lawyers\/Tax-advisors\/Auditors","Lawyers, tax consultants, auditors","Consultant"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/","url":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/","name":"Baker McKenzie advises CureVac on strategic partnership with GSK - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg","datePublished":"2020-07-22T15:38:27+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/07\/a-ulmereilfort_620_b1746f11db.jpg","width":620,"height":347},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/baker-mckenzie-advises-curevac-on-strategic-partnership-with-gsk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Baker McKenzie advises CureVac on strategic partnership with&nbsp;GSK"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=43336"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/43336\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/35094"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=43336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=43336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=43336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}